Published: 18 October 2018
Committees
Summary of recommendations from the out-of-session meeting of the Medicines Assessment Advisory Committee from 29 August to 1 October 2018
1. |
Applications for consent to distribute a new medicine under section 20 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2)) |
1.1 |
Liposomal Doxorubicin SUN, 2 mg/mL concentrate for infusion (TT50-9159) Pharmacy Retailing (NZ) LtdSecretary's note - This recommendation has not been published because the applicant withdrew this application on 16 October 2018, following notification of the recommendation |
